Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.6%

2 terminated/withdrawn out of 36 trials

Success Rate

90.5%

+4.0% vs industry average

Late-Stage Pipeline

19%

7 trials in Phase 3/4

Results Transparency

5%

1 of 19 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A
15(60.0%)
Phase 4
5(20.0%)
Phase 2
3(12.0%)
Phase 3
2(8.0%)
25Total
N/A(15)
Phase 4(5)
Phase 2(3)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (36)

Showing 20 of 36 trials
NCT07310992Not ApplicableNot Yet Recruiting

Effect of Meditation as an Adjunct to Cardiac Rehabilitation

Role: lead

NCT07259733Not ApplicableRecruiting

Rapid Management of Resistant Hypertension in the Public Health System (Fast Control)

Role: lead

NCT06786819Not ApplicableRecruiting

Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project

Role: collaborator

NCT04402931Not ApplicableCompleted

Randomized Trial of Transcatheter Valve-in-Valve vs Redo Surgery for Bioprosthetic Mitral Dysfunction

Role: lead

NCT06688448Not ApplicableRecruiting

Valvular Assessment of New Generation Aortic Replacement Devices

Role: lead

NCT06721442Phase 4Completed

Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG Study

Role: collaborator

NCT04723355Not ApplicableCompleted

A Comparative Study of an Innovative 3-lead Wireless Water Resistant Holter System and a Conventional Holter System

Role: collaborator

NCT05336357Not ApplicableRecruiting

Non-invasive Goal-directed thErapy oN cIrcUlatory Shock

Role: collaborator

NCT05081414Not ApplicableCompleted

Efficacy of the PEAC-IC: a Randomized Controlled Clinical Trial

Role: collaborator

NCT05363696Completed

The REPLICCAR Registry and The Statewide Quality Improvement Initiative

Role: collaborator

NCT05160311Not ApplicableUnknown

Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility

Role: lead

NCT04531007Not ApplicableUnknown

Imaging and Physiology for Intermediate Left Main Stem Stenosis

Role: lead

NCT02212470Phase 4Completed

Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery

Role: lead

NCT02672345Completed

Systemic Inflammatory Response Evaluation With the Use of Inhaled Anesthetic Sevoflurane During CPB

Role: lead

NCT02671084Phase 4Terminated

Sevoflurane and Percutaneous Coronary Intervention by Stent

Role: lead

NCT04321473Unknown

Registry on Left Main Coronary Artery Bifurcation Percutaneous Intervention

Role: collaborator

NCT02711384Completed

MACBIS50 in Patients Undergoing CAG During Normothermic CPB Phase.

Role: lead

NCT00123916Phase 3Completed

BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease

Role: collaborator

NCT03949439Completed

Pre-frailty and Rehospitalization in Cardiac Surgery

Role: lead

NCT01608477Unknown

Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation

Role: collaborator